Case Reports
doi: 10.4103/0301-4738.42431.
Contact allergic dermatitis and periocular depigmentation after using olapatidine eye drops
- PMID: 18711283
- PMCID: PMC2636135
- DOI: 10.4103/0301-4738.42431
Item in Clipboard
Case Reports
Contact allergic dermatitis and periocular depigmentation after using olapatidine eye drops
Indian J Ophthalmol.
2008 Sep-Oct.
No abstract available
Similar articles
-
The utility of chamber scarification in the detection of allergic contact dermatitis to ophthalmic solutions.Dermatitis. 2014 Nov-Dec;25(6):373-4. doi: 10.1097/DER.0000000000000076. Dermatitis. 2014. PMID: 25384224 No abstract available.
-
Periorbital Allergic Contact Dermatitis Due to Ketotifen.Dermatitis. 2017 Mar/Apr;28(2):164-165. doi: 10.1097/DER.0000000000000264. Dermatitis. 2017. PMID: 28169851 No abstract available.
-
Post-inflammatory depigmentation following allergic contact dermatitis to chloroxylenol.Br J Dermatol. 2001 Jun;144(6):1275-6. doi: 10.1046/j.1365-2133.2001.04256.x. Br J Dermatol. 2001. PMID: 11422065 No abstract available.
-
Allergic Contact Dermatitis to Ophthalmic Medications: Relevant Allergens and Alternative Testing Methods.Dermatitis. 2016 Nov/Dec;27(6):333-347. doi: 10.1097/DER.0000000000000224. Dermatitis. 2016. PMID: 27775976 Review.
-
Strong irritants masquerading as skin allergens: the case of benzalkonium chloride.Contact Dermatitis. 2004 Apr;50(4):213-7. doi: 10.1111/j.0105-1873.2004.00331.x. Contact Dermatitis. 2004. PMID: 15186375 Review.
Cited by
-
Chemical-Induced Vitiligo.Dermatol Clin. 2017 Apr;35(2):151-161. doi: 10.1016/j.det.2016.11.006. Dermatol Clin. 2017. PMID: 28317525 Free PMC article. Review.
-
Quaternary Ammonium Compounds and Contact Dermatitis: A Review and Considerations During the COVID-19 Pandemic.Clin Cosmet Investig Dermatol. 2023 Jun 30;16:1721-1728. doi: 10.2147/CCID.S410910. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37409071 Free PMC article. Review.
-
Chemical leucoderma: Indian scenario, prognosis, and treatment.Indian J Dermatol. 2010 Jul-Sep;55(3):250-4. doi: 10.4103/0019-5154.70674. Indian J Dermatol. 2010. PMID: 21063517 Free PMC article.
-
Allergic reactions to atropine eye drops for retardation of progressive myopia in children.Indian J Ophthalmol. 2018 Oct;66(10):1446-1450. doi: 10.4103/ijo.IJO_165_18. Indian J Ophthalmol. 2018. PMID: 30249831 Free PMC article.
References
-
- Lichtenstein SJ, Pasquine TA, Edwards MR, Wells DT, Gross RD, Robertson SM. Safety and tolerability of olopatadine 0.2% in children and adolescents. 2007;23:366–71. - PubMed
-
- Abelson MB. A review of olopatadine for the treatment of ocular allergy. Exp Opin Pharmacother. 2004;5:1979–94. - PubMed
-
- Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, et al. Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: A randomized, double-masked environmental study. Clin Ther. 2004;26:1237–48. - PubMed
-
- Katelaris CH, Ciprandi G, Missotten L, Turner FD, Bertin D, Berdeaux G, et al. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis. Clin Ther. 2002;24:1561–75. - PubMed
-
- Spangler DL, Bensch G, Berdy GJ. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% opthalmic solution in the conjunctival allergen challenge model. Clin Ther. 2001;23:1272–80. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
